DARZALEX

daratumumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

90 regulatory and trial events tracked for DARZALEX, covering 2015-11-16 to 2026-08-26. Get the full timeline:

Most recent: EMA Authorised: Darzalex (daratumumab)